Immunome IMNM Short- and long-term operating lease liabilities
Short- and long-term operating lease liabilities at other companies
Other financials
Where this comes from
Reported directly by Immunome in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Immunome’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunome's short- and long-term operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunome's short- and long-term operating lease liabilities?
- Immunome (IMNM) reported short- and long-term operating lease liabilities of -$161K in Q1 2026.
- How has Immunome's short- and long-term operating lease liabilities changed year-over-year?
- Immunome's short- and long-term operating lease liabilities decreased by 159.7% year-over-year, from -$62K to -$161K.